Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

HEALTHCARE SERVICES GROUP Q1 REVENUE UP 3.4%

Healthcare Services Group reported first-quarter revenue of $462.8 million, up 3.4% from a year earlier, as the company said new client wins and high retention rates lifted top-line growth.

Net income was $26.1 million, while diluted earnings per share came in at $0.37.

Operating cash flow reached $43.7 million in the quarter. Excluding the $20.3 million increase in payroll accrual, cash flow from operations was $23.4 million.

The company ended the quarter with $214.6 million in cash and marketable securities and an unused $300.0 million revolving credit facility.

Cost of services totaled $386.9 million, or 83.6% of revenue. SG&A was $42.0 million, and after adjusting for a $1.6 million decrease in deferred compensation, SG&A was $43.6 million, or 9.4% of revenue.

By segment, environmental services revenue was $208.3 million with a 12.1% margin, while dietary services revenue was $254.5 million with a 9.0% margin.

The company repurchased $24.0 million of its stock during the quarter and said it still has 9.2 million shares remaining under its February 2026 authorization.

Healthcare Services Group reiterated its 2026 outlook for mid-single-digit revenue growth. Today the company's shares have moved -2.95% to a price of $19.11. For the full picture, make sure to review HEALTHCARE SERVICES GROUP INC's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS